181 related articles for article (PubMed ID: 11298128)
1. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase.
Kuijpers TW; van den Berg JM; Tool AT; Roos D
Clin Exp Immunol; 2001 Mar; 123(3):412-20. PubMed ID: 11298128
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses.
Henig NR; Aitken ML; Liu MC; Yu AS; Henderson WR
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):523-7. PubMed ID: 10934081
[TBL] [Abstract][Full Text] [Related]
3. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
Schuster DP; Metzler M; Opal S; Lowry S; Balk R; Abraham E; Levy H; Slotman G; Coyne E; Souza S; Pribble J;
Crit Care Med; 2003 Jun; 31(6):1612-9. PubMed ID: 12794395
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.
Bleeker WK; Teeling JL; Verhoeven AJ; Rigter GM; Agterberg J; Tool AT; Koenderman AH; Kuijpers TW; Hack CE
Blood; 2000 Mar; 95(5):1856-61. PubMed ID: 10688848
[TBL] [Abstract][Full Text] [Related]
5. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model.
Henderson WR; Lu J; Poole KM; Dietsch GN; Chi EY
J Immunol; 2000 Mar; 164(6):3360-7. PubMed ID: 10706731
[TBL] [Abstract][Full Text] [Related]
7. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
[TBL] [Abstract][Full Text] [Related]
8. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis.
Caplan MS; Lickerman M; Adler L; Dietsch GN; Yu A
Pediatr Res; 1997 Dec; 42(6):779-83. PubMed ID: 9396557
[TBL] [Abstract][Full Text] [Related]
9. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus.
Velasquez LA; Maisey K; Fernandez R; Valdes D; Cardenas H; Imarai M; Delgado J; Aguilera J; Croxatto HB
Hum Reprod; 2001 Aug; 16(8):1583-7. PubMed ID: 11473946
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis.
Bedirli A; Gokahmetoglu S; Sakrak O; Soyuer I; Ince O; Sozuer E
Eur Surg Res; 2004; 36(3):136-41. PubMed ID: 15178901
[TBL] [Abstract][Full Text] [Related]
11. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture.
Kolko M; Rodriguez de Turco EB; Diemer NH; Bazan NG
Neurosci Lett; 2003 Feb; 338(2):164-8. PubMed ID: 12566178
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.
Opal S; Laterre PF; Abraham E; Francois B; Wittebole X; Lowry S; Dhainaut JF; Warren B; Dugernier T; Lopez A; Sanchez M; Demeyer I; Jauregui L; Lorente JA; McGee W; Reinhart K; Kljucar S; Souza S; Pribble J;
Crit Care Med; 2004 Feb; 32(2):332-41. PubMed ID: 14758145
[TBL] [Abstract][Full Text] [Related]
13. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
Koike H; Imanishi N; Natsume Y; Morooka S
Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis.
Hofbauer B; Saluja AK; Bhatia M; Frossard JL; Lee HS; Bhagat L; Steer ML
Gastroenterology; 1998 Nov; 115(5):1238-47. PubMed ID: 9797380
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase.
Arai H
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():83-94. PubMed ID: 12432911
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids.
Marathe GK; Silva AR; de Castro Faria Neto HC; Tjoelker LW; Prescott SM; Zimmerman GA; McIntyre TM
J Lipid Res; 2001 Sep; 42(9):1430-7. PubMed ID: 11518762
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
18. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
Chaithra VH; Jacob SP; Lakshmikanth CL; Sumanth MS; Abhilasha KV; Chen CH; Thyagarajan A; Sahu RP; Travers JB; McIntyre TM; Kemparaju K; Marathe GK
J Lipid Res; 2018 Nov; 59(11):2063-2074. PubMed ID: 30139761
[TBL] [Abstract][Full Text] [Related]
19. Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis.
Ogden F; DeCoster MA; Bazan NG
J Neurosci Res; 1998 Sep; 53(6):677-84. PubMed ID: 9753196
[TBL] [Abstract][Full Text] [Related]
20. The macrophage response to endotoxin requires platelet activating factor.
Bulger EM; Arbabi S; Garcia I; Maier RV
Shock; 2002 Mar; 17(3):173-9. PubMed ID: 11900334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
